Khalil Bouayadi

560 total citations
18 papers, 478 citations indexed

About

Khalil Bouayadi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Khalil Bouayadi has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Biotechnology. Recurrent topics in Khalil Bouayadi's work include DNA Repair Mechanisms (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Khalil Bouayadi is often cited by papers focused on DNA Repair Mechanisms (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Khalil Bouayadi collaborates with scholars based in France, Netherlands and Italy. Khalil Bouayadi's co-authors include Bernard Salles, Jean‐Sèbastien Hoffmann, Christophe Cazaux, Mathilde Fréchet, Claire Lesca, Yvan Canitrot, Philippe Mondon, Céline Monnet, Fabien Crozet and Stéphane Emond and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Khalil Bouayadi

18 papers receiving 452 citations

Peers

Countries citing papers authored by Khalil Bouayadi

Since Specialization

Citations

This map shows the geographic impact of Khalil Bouayadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Bouayadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Bouayadi more than expected).

Fields of papers citing papers by Khalil Bouayadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Bouayadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Bouayadi. The network helps show where Khalil Bouayadi may publish in the future.

Co-authorship network of co-authors of Khalil Bouayadi

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Bouayadi. A scholar is included among the top collaborators of Khalil Bouayadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Bouayadi. Khalil Bouayadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions 2015 ·Frontiers in Immunology ·Céline Monnet, Sylvie Jorieux, (unknown), Nathalie Fournier, Khalil Bouayadi, Christophe de Romeuf, Christian K. Behrens, Alexandre Fontayne, Philippe Mondon	35
2	Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody 2014 ·mAbs ·Céline Monnet, Sylvie Jorieux, (unknown), (unknown), Alexandra Jacquet, Nathalie Fournier, Fabien Crozet, Christophe de Romeuf, Khalil Bouayadi, (unknown), Christian K. Behrens, Philippe Mondon, Alexandre Fontayne	38
3	Anti-HER3 Domain 1 and 3 Antibodies Reduce Tumor Growth by Hindering HER2/HER3 Dimerization and AKT-Induced MDM2, XIAP, and FoxO1 Phosphorylation 2013 ·Neoplasia ·Yassamine Lazrek, Olivier Dubreuil, Véronique Garambois, Nadège Gaborit, Christel Larbouret, Christophe Le Clorennec, (unknown), Wilhem Leconet, Marta Jarlier, Martine Pugnière, Nadia Vié, Bruno Robert, Céline Monnet, Khalil Bouayadi, (unknown), Philippe Mondon, André Pèlegrin, Thierry Chardès	35
4	Affinity Maturation of Antibodies: Optimized Methods to Generate High-Quality ScFv Libraries and Isolate IgG Candidates by High-Throughput Screening 2012 ·Methods in molecular biology ·(unknown), Céline Monnet, Olivier Dubreuil, (unknown), Fabien Crozet, Khalil Bouayadi, (unknown), Philippe Mondon	17
5	Mutagen™: A Random Mutagenesis Method Providing a Complementary Diversity Generated by Human Error-Prone DNA Polymerases 2010 ·Methods in molecular biology ·Philippe Mondon, David Grand, (unknown), Stéphane Emond, Khalil Bouayadi, (unknown)	5
6	Alternative-splicing-based bicistronic vectors for ratio-controlled protein expression and application to recombinant antibody production 2009 ·Nucleic Acids Research ·(unknown), (unknown), Corinne Hiéblot, Philippe Mondon, Éric Lacazette, Khalil Bouayadi, (unknown), Christian Touriol, Hervé Prats	16
7	Combinatorial engineering to enhance thermostability of amylosucrase 2008 ·Protein Science ·Stéphane Emond, Isabelle André, (unknown), (unknown), Philippe Mondon, Khalil Bouayadi, (unknown), Pierre Monsan, Magali Remaud‐Siméon	29
8	A novel random mutagenesis approach using human mutagenic DNA polymerases to generate enzyme variant libraries 2008 ·Protein Engineering Design and Selection ·Stéphane Emond, Philippe Mondon, Sandra Pizzut‐Serin, (unknown), Fabien Crozet, Khalil Bouayadi, (unknown), Gabrielle Potocki-Véronèse, Pierre Monsan, Magali Remaud‐Siméon	21
9	Optimized and Automated Protocols for High-Throughput Screening of Amylosucrase Libraries 2007 ·SLAS DISCOVERY ·Stéphane Emond, Gabrielle Potocki-Véronèse, Philippe Mondon, Khalil Bouayadi, (unknown), Pierre Monsan, Magali Remaud‐Siméon	19
10	Method for generation of human hyperdiversified antibody fragment library 2007 ·Biotechnology Journal ·Philippe Mondon, (unknown), (unknown), Fabien Crozet, Khalil Bouayadi, (unknown)	18
11	Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs 1998 ·Proceedings of the National Academy of Sciences ·Yvan Canitrot, Christophe Cazaux, Mathilde Fréchet, Khalil Bouayadi, Claire Lesca, Bernard Salles, Jean‐Sèbastien Hoffmann	172
12	Enzymatic Activities Involved in the DNA Resynthesis Step of Nucleotide Excision Repair Are Firmly Attached to Chromatin 1997 ·Nucleic Acids Research ·Khalil Bouayadi, Anneke van Hoffen, A.S. Balajee, A.T. Natarajan, A.A. van Zeeland, Leon H.F. Mullenders	13
13	Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine. 1997 ·PubMed ·Khalil Bouayadi, Jean‐Sèbastien Hoffmann, (unknown), (unknown), Jean-Paul Reynes, Christophe Cazaux	32
14	Influence of DNA supercoiling on cisplatin toxicity in Escherichia coli K-12 1995 ·Mutation Research Letters ·Khalil Bouayadi, Bernard Salles	5
15	UV Induction of Excision Repair Enzymes Detected in Protein Extracts from Schizosaccharomyces pombe 1994 ·Biochemical and Biophysical Research Communications ·(unknown), Khalil Bouayadi, Patrick Calsou, Bernard Salles	3
16	Multiple mechanisms of resistance to cisplatin toxicity in an Escherichia coli K12 mutant 1994 ·Toxicology ·Bernard Salles, Patrick Calsou, Khalil Bouayadi, (unknown)	5
17	Resistance to cisplatin in an E. coli B/r NalR mutant 1993 ·Mutation Research/DNA Repair ·Khalil Bouayadi, Giuseppe Villani, Bernard Salles	2
18	In vitro evolution of cisplatin/DNA monoadducts into diadducts is dependent upon superhelical density 1992 ·Biochemical and Biophysical Research Communications ·Khalil Bouayadi, Patrick Calsou, Antonia M. Pedrini, Bernard Salles	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact